$NMAD Income Statement | Understand Stock

$NMAD

$4.03 +$0.09 (2.28%) Close

Financial Statements

In USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Costs and expenses:
General and Administrative Expense
Patent and licensing legal and filing fees and costs
Other costs and expenses
Research and development costs
Total costs and expenses
Loss from operations
Interest Income
Interest Expense
Realized loss on digital assets
Foreign currency gain (loss)
Other income
Net loss
Series B Convertible Preferred Stock 8% cumulative dividend
Net loss attributable to common stockholders
Net loss per common share – basic and diluted
Weighted average common shares outstanding – basic and diluted
Earnings Per Share, Diluted
Weighted Average Number of Shares Outstanding, Diluted

Comments